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Encapsulation of three forms of lactoferrin (Lf) (apo-, native- and holo-) was undertaken using the 2 
novel impinging aerosol technique (Progel). The micro-gel particles were produced from a 2% 3 
(w/w) solution of Lf and alginate (at equal mixing ratio) using 0.1 M CaCl2 as the cross-linking 4 
solution. An encapsulation efficiency of 68 − 88% was achieved based on the total amount of Lf 5 
entrapped in alginate micro-gel matrix. Increasing the CaCl2 concentration to 0.2 M reduced the 6 
encapsulation efficiency. An in-vitro digestion study conducted in simulated gastric fluid (SGF) and 7 
intestinal fluid (SIF) used pepsin and pancreatin (porcine) enzymes, respectively. Lf encapsulated 8 
micro-gel particles were able to retain significantly higher amount (76 − 89%) of Lf (apo- and 9 
native- forms) when digested in the SGF for 2 hours as compared to their corresponding un-10 
encapsulated pure Lf (41 − 58%). The effect of encapsulation on digestibility in SGF of holo-Lf 11 
was minimal. Digestion of all forms of Lf, pure or encapsulated, in the SIF was very rapid. Within 12 
10 min, apo- and native-Lf were completely digested, while holo-Lf, exhibited some resistance as 13 
less than 5% remained after 10 min. This study showed that encapsulating apo- and native-Lf in 14 
alginate micro-gel particles can provide protection from the action of pepsin in the SGF and allow 15 
their releases in the SIF.  16 
Keywords: Lactoferrin, alginate, micro-gel particles, in-vitro digestion, simulated gastric fluid, 17 
simulated intestinal fluid. 18 
1. Introduction 19 
The possibility of supplementing different food products other than baby formula with lactoferrin 20 
(Lf) has generated much attention in recent years because of its ability to exert many health 21 
beneficial effects for humans. Antimicrobial, anti-inflammatory, immunomodulatory and anti-22 
carcinogenic effects are a few of the claimed health benefits of Lf (Legrand et al., 2008). These 23 
physiological effects of Lf are attributed by its strongly cationic nature (Brock, 2002) with or 24 
without the conjunction of its ability to bind iron with high affinity (KD~ 10-20 M) (Moore, 25 
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iron binding ability and this has enabled its use as nutritional iron supplement (Steijns, 2001). 27 
Greater bioavailability of iron from Lf as compared to inorganic iron has been reported by several 28 
researchers (Ueno, Ueda, Morita, Kakehi, & Kobayashi, 2012; Hu et al., 2008). 29 
To enable the use of Lf as a food ingredient, apart from optimising the processing conditions, it is 30 
required that it can withstand the harsh gastrointestinal conditions to reach the site of digestion and 31 
absorbance, the small intestine in its bioactive state (Lönnerdal, & Kelleher, 2009). Researches in 32 
the past have shown that oral delivery of Lf leads to diminished effects due to its breakdown by 33 
gastric conditions (Steijns, Brummer, Troost, & Saris, 2001; Eriksen et al., 2010). Different forms 34 
of Lf, iron-free (apo-), iron-saturated (holo-) or native-Lf (composed of a mixture of apo- and holo-35 
Lf) (Steijns, & van Hooijdonk, 2000) and/or monoferric Lf (iron bound either in N or C lobe) 36 
(Brisson, Britten, & Pouliot, 2007) possess different physico-chemical properties (Bokkhim, 37 
Bansal, Grøndahl, & Bhandari, 2013). The differences in their molecular conformation and other 38 
properties can lead to difference in their resistance towards the harsh processing and gastrointestinal 39 
conditions. Research has shown that iron saturated holo-Lf is less susceptible to the gastric 40 
degradation (Steijns et al., 2001; Brock, Arzabe, Lampreave, & Piñeiro, 1976) and thermal 41 
denaturation (Sánchez et al., 1992; Conesa et al., 2008) compared to apo-Lf.   42 
In the food sector, microencapsulation has been in use for more than 75 years to entrap in a matrix 43 
or coat sensitive compounds such as vitamins, antioxidants, flavours, bioactives, enzymes, peptides, 44 
proteins and microbial cells (Pegg, & Shahidi, 2007; Millqvist-Fureby, 2009; Gombotz, & Wee, 45 
1998; Ding, & Shah, 2007). Various matrix materials such as starches, sugars, cellulose, 46 
hydrocolloids, lipids, and proteins have been used (Zuidam, & Shimoni, 2010). Encapsulation 47 
offers immobilization, protection, controlled release, structure and functionalization for sensitive 48 
compounds (Poncelet, 2006). Amongst these different microencapsulation materials, alginate gel 49 
particles have been reported to enhance the stability against processing and gastric conditions (pH 50 
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and proteolytic enzymes) for a number of water insoluble and micro-particulate core compounds 51 
(Rayment et al., 2009; Brownlee, Seal, Wilcox, Dettmar, & Person, 2009).  52 
Alginate is a natural polysaccharide, composed of unbranched binary copolymers of (1→ 4) linked 53 
β-D mannuronic acid (M) and α-L-guluronic acid (G) residues of widely varying composition and 54 
sequence (Draget, 2009). Because of its biocompatibility, safety and ability to form gel particles 55 
under mild conditions in the presence of calcium ions, it has been extensively used for 56 
encapsulation and immobilization of sensitive active ingredients for food applications (Martinsen, 57 
Storrø, & Skjåk-Bræk, 1992). The non-toxic nature yet synergistic effect of calcium on humans and 58 
animals has enabled its use as the most favourable cross-linking ion in alginate based delivery 59 
system (Draget & Taylor, 2011). In-vitro studies have shown that alginates retard the actions of a 60 
range of digestive enzymes by limiting the availability of the enzyme to the substrates (Brownlee et 61 
al., 2009). Andresen, Skipnes, Smidsrød, Ostgaard and Hemmer (1977) reported that calcium 62 
treated alginate forms gel networks characterized by a pore size between 5 and 150 nm and allows 63 
the diffusion of water soluble components with molecular weight as high as 300 kDa, in and out of 64 
the calcium alginate gel  network (Tanaka, Matsumura, & Veliky, 1984; Pothakamury, & Barbosa-65 
Cánovas, 1995). Degradation of alginate gel networks in the presence of chelating agents (eg. 66 
citrates and phosphates) can also lead to release of encapsulated macromolecules such as proteins 67 
(Gombotz & Wee, 1998). Furthermore, alginate is an anionic polysaccharide and therefore 68 
electrostatic interactions (Draget, 2009) can occur in the presence of charged polymers (eg. cationic 69 
proteins such as Lf) leading to a sustained release of macromolecules from the gel particles (Wells, 70 
& Sheardown, 2007; Bokkhim, Bansal, Grøndahl, & Bhandari, 2014). Research has shown that 71 
electrostatic as well as other intermolecular interactions occur between Lf and alginate and that the 72 
extent of interactions is affected by the form of Lf (Peinado, Lesmes, Andrés, & McClements, 73 
2010; Bokkhim, Bansal, Grøndahl, & Bhandari, 2015). These interactions minimise the loss of 74 
entrapped Lf by diffusion, lower at pH 4 compared to pH 7 for native- and holo-Lf, thus ensuring 75 
the stability of Lf within the alginate gel matrix (Bokkhim et al., 2014). The release of encapsulated 76 
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gel particles or a combination of both (Kuang, Oliveira, & Crean, 2010). In the human intestine, the 78 
presence of chelating agents such as lactate, citrates and phosphates (Coppi, Iannuccelli, Leo, 79 
Bernabei, & Cameroni, 2001) and other cations such as sodium ions (Gombotz & Wee, 1998) play 80 
an important role in the destabilization of cross-linked alginate gel networks by removing the 81 
calcium ions. In-vitro studies conducted on alginate gel particles has reported that the gel particles 82 
were resistant to the gastric conditions while disintegrating in the intestinal conditions (Rayment et 83 
al., 2009) which render them as a potential vehicle for controlled delivery. 84 
The objective of this study is to encapsulate Lf in alginate micro-gel particles using a locally 85 
developed impinging aerosol technique (Bhandari, 2009) in order to develop Lf encapsulated 86 
micro-gel particles with enhanced technological properties for their potential use in food 87 
formulations. In-vitro stability and release of Lf from the micro-gel particles were evaluated in 88 
simulated gastric and intestinal fluids in the presence of proteolytic enzymes pepsin and pancreatin, 89 
respectively.    90 
2. Materials and Methods 91 
2.1. Materials 92 
Bovine lactoferrin (NatraFerrin), with iron saturation levels of approximately 1% (apo-) and 13% 93 
(native-) were provided by MG Nutritionals®, Burnswick, Australia. Sodium alginate (PE 12001-94 
13.8 EN), GRINDSTED® Alginate FD 155 (M/G ratio 1.5; molecular mass 140 kDa) was from 95 
Danisco Australia Pty. Ltd., Sydney, Australia. Calcium chloride dihydrate (99%), bile salts (from 96 
ox gall; BL038-25G), sodium chloride and tri-sodium citrate dehydrate were purchased from Chem-97 
supply Pty. Ltd, SA, Australia. Pepsin from porcine gastric mucosa (P6887; 3200-4500 units/mg 98 
protein), pancreatin from porcine pancreas (P-7545; Activity equivalent to 8×U.S.P. specification), 99 
bis (2-hydroxymethyl) iminotris-[hydroxymethyl] methane) (bis-tris) (purity > 98%), monobasic 100 
potassium phosphate, sodium hydroxide, sodium acetate trihydrate, Trizma® base, sodium 101 
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99%). Acetic acid (99%), hydrochloric acid (concentration ~ 31.5%) and methanol (99.8%) were 103 
from Labtek Pty. Ltd., Brendale, Australia. Sodium dodecyl sulphate (SDS) was from Amresco, 104 
Solon, USA and glycerol was from Ajax Finechem Pty. Ltd., Taren Point, Australia. The dyes, 105 
bromophenol blue and Coomassie brilliant blue G-250, Mini-PROTEAN® TGXTM Gels (4 – 20%, 106 
15 wells comb, 15 µL) were from BIO-RAD, Gladesville, Australia. Cellulose acetate membrane 107 
filter (Ø=47 mm, pore size=0.45µm) was purchased from Advantec®, Toyo Roshi Kaisha, Ltd., 108 
Japan. All chemicals, unless otherwise stated, were of analytical grade. Millipore water was used 109 
for all experiments. Iron saturated holo-Lf (99.7%) was prepared according to the method described 110 
by Bokkhim, Tran, Bansal, Grøndahl and Bhandari (2014). 1% (w/v) solution of native-Lf was 111 
prepared in 10 mM Tris-Cl buffer containing 75 mM NaCl, pH adjusted to 7.2 with HCl solution. 112 
Calculated volume of fresh ferric nitrilotriacetic acid (FeNTA) solution [9.9 mM ferric nitrate and 113 
8.5 mM nitrilotriacetic acid, pH adjusted to 7.0 with solid sodium bicarbonate] was added to the Lf 114 
solution to achieve a molar ratio Lf:iron of 1:2; incubated at room temperature for an hour and 115 
finally dialysed against Millipore water for 48 hours with three changes of water. The dialysed iron 116 
saturated Lf solution was freeze dried prior to use in the study.  117 
2.2. Encapsulation of Lf in alginate micro-gel particles 118 
Two percent solids by weight solutions of sodium alginate (Alg) and the three forms of Lf (apo-, 119 
native- & holo-) were prepared separately in Millipore water. To dissolve sodium alginate, water at 120 
40 ºC was used. The solutions were prepared by mixing for 2 hours at 600 rpm using a high shear 121 
homogenizer (IKA ® RW 20 digital, USA) and allowed to stand at room temperature for another 2 122 
hours. Subsequently the alginate and the Lf solution were mixed at equal ratio (Alg:Lf = 1:1) and 123 
left standing overnight to remove any trapped air.  124 
Micro-encapsulated Lf-alginate particles were prepared using the impinging aerosol technique 125 
(Progel microencapsulating device, Bhandari, 2009) (Fig. 1). This continuous micro-gel forming 126 
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Turner, Coombes, Bostrom, & Bhandari, 2011; Hariyadi et al., 2012). The Lf-alginate mixture was 128 
introduced from a nozzle into a close upright chamber at an air pressure of 500 kPa. A solution of 129 
calcium chloride (0.1 M) was introduced from another nozzle fitted at the bottom of the device at an 130 
air pressure of 200 kPa. The cascading fine droplets of the Lf-alginate mixture came in contact with 131 
the uprising fine mist of calcium chloride inside the device, thus creating gelled particles instantly. 132 
The micro-gel particles were collected from the bottom outlet along with the calcium chloride 133 
solution and allowed to cure in the cross-linking solution for 30 minutes. The time interval of 30 134 
minutes for cross-linking of 2% Lf-alginate beads (Lf:Alg = 1:1) was adapted based on the study 135 
conducted by Bokkhim et al., 2014. After curing, the product was collected using vacuum filtration 136 
with a filter paper (Advantec, Quantitative Filter Paper, Grade no. 3, Japan). The product was 137 
washed twice with Millipore water to remove excess calcium, and then frozen at -18 °C and freeze-138 
dried (Christ, ALPHA 1-4 LSC, Osterode, Germany) under the standard condition; ice condenser 139 
temperature of  - 60 ± 5 ºC, shelf temperature of 10 ± 5 ºC and vacuum of 0.021 − 0.040 mbar for 140 
72 hours. To study the effect of the calcium content in the cross-linking solution, micro-gel particles 141 
of similar composition were produced using 0.2M CaCl2. Control blank gel particles were prepared 142 
from 2% alginate alone. The freeze dried micro-gel particles were stored in an air-tight aluminium 143 
foil bag in a freezer (-18 C) until future characterization. Sample names are outlined in Table 1.  144 
The product recovery and encapsulation efficiency after freeze drying of the gel micro-particles 145 
were calculated from equations 1 and 2, respectively. 146 
Product recovery =                                             (1) 147 
Encapsulation efficiency =                    (2) 148 
Figure 1  149 
2.3. Characterization of Lf encapsulated alginate micro-gel particles 150 
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The micro-gel particles were characterized for their calcium and protein contents. The analyses 152 
were conducted on freeze dried micro-gel particles. The calcium content of the micro-gel particles 153 
was determined by Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES) (Varian 154 
Vista Pro Radial ICP-OES system, Melbourne, Australia) after digesting the micro-gel particles in 155 
nitric:perchloric acid (5:1). The calcium values were expressed per unit mass of alginate after 156 
deducting the protein from the total mass. The protein content was analyzed following the 157 
combustion protocol of Dumas method (Rayment, & Higginson, 1992) and the values are expressed 158 
in percentage of dry weight.  159 
2.3.2. Particle size measurement 160 
The particle size of the freshly prepared (non-freeze dried) micro-gel particles encapsulating native-161 
Lf were measured using a Mastersizer 2000 (Malvern Instruments Ltd., Worcestershire, UK). This 162 
method is based on laser diffraction by suspended particles in distilled water, at laser obscuration of 163 
≥ 15% and laser intensity ≥ 75%. The results are expressed in volume weighted mean, D (4,3). The 164 
freshly prepared micro-gel particles were collected after filtration and washed with Millipore water. 165 
These washed micro-gel particles were re-suspended in Millipore water prior to particle size 166 
measurement. The particle size of freeze dried micro-gel particles after rehydration was also 167 
measured using the same method. All measurement were conducted at room temperature (22 ± 2 168 
ºC). 169 
2.4. In-vitro digestion of different forms of Lf 170 
The protocol for in-vitro digestion of Lf or encapsulated Lf in micro-gel particles was developed 171 
after comparative study of similar in-vitro digestion protocols used for different proteins. Dupont et 172 
al. (2010) for food proteins, Mandalari et al. (2008) for almond protein, Eriksen et al. (2010) for 173 
caprine whey proteins and Almaas et al. (2006) for caprine whey proteins including bovine Lf. 174 
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processing. In this study, taking into account, the amount of calcium which is also ingested along 176 
with the encapsulated Lf through micro-gel particles, a protein concentration of 25 mg Lf/mL was 177 
used for gastric processing. 178 
2.4.1. Simulated gastric digestion 179 
The three different forms of Lf (apo-, native- and holo-) were digested in simulated gastric fluid 180 
(SGF) (0.2% NaCl solution in Millipore water, pH adjusted to 2.0 with 1 M HCl, 4500 U 181 
pepsin/mL). To 125 mg of Lf, 5 mL of SGF was added to achieve 180 U pepsin/mg Lf. The Lf 182 
samples were incubated at 37 ºC under constant horizontal shaking (100 strokes/min) (Julabo, SW-183 
22, GmbH, Germany). After 30, 60, 90 and 120 minutes, 100 µL of the digested sample was 184 
removed and diluted with 2.4 mL of 0.1 M sodium bicarbonate solution (pH ~ 8.2) to achieve 0.1% 185 
Lf. The high pH was used to reduce the activity of the pepsin enzyme. This diluted digested sample 186 
was used immediately to prepare samples for SDS-PAGE gel electrophoresis (described below). 187 
2.4.2. Simulated intestinal digestion 188 
To study the effect of pancreatin on the different forms of Lf (apo-, native- & holo-), in-vitro 189 
digestion of Lf was done in simulated intestinal fluid (SIF) prepared according to US Pharmacopeia 190 
with slight modification in pH. 50 mg Lf was dissolved in 2 mL Millipore water. Then 2 mL of pre-191 
warmed SIF (37 ºC; 0.68% monobasic potassium phosphate; 0.5% bile salts; 1.0% pancreatin; pH 192 
8.5) was added, pH was adjusted to 7.5 and incubated at 37 ºC under constant horizontal shaking 193 
(100 strokes/min). After 10, 20, 30 and 60 minutes, 100 µL of the sample was removed and diluted 194 
with 1.15 mL of Millipore water to achieve 0.1% Lf.  This diluted digested sample was used for 195 
SDS-PAGE gel electrophoresis immediately. 196 
2.5. In-vitro digestion of encapsulated Lf  197 
2.5.1. Simulated gastric digestion 198 
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mg Lf), 5 mL of pre-warmed (37 ºC) SGF was added (180 U pepsin/mg Lf). Samples were 200 
incubated in a water bath under constant shaking (37 ºC, 100 horizontal strokes/min) for a set length 201 
of time. After 30, 60, 90 and 120 minutes, the samples were filtered through cellulose acetate 202 
membrane filter (0.45 µm) under vacuum and washed with Millipore water. The gel particles were 203 
collected and dissolved in 12.5 mL of 0.1 M sodium citrate solution under constant shaking at 37 204 
ºC. The activity of the pepsin enzyme was reduced because of high pH of sodium citrate (~ 8.4). 205 
Once completely dissolved, 1 mL of the digested sample was further diluted with 9 mL of Millipore 206 
water to achieve 0.1% Lf content. This diluted mixture was the base sample for SDS-PAGE gel 207 
electrophoresis. As a control sample in SDS-PAGE gel electrophoresis, micro-gel particles which 208 
had not been exposed to SGF were dissolved in 0.1 M sodium citrate solution (0.5% Lf). After 209 
complete dissolution of the micro-gel particles, 1 mL of this solution was diluted with 4 mL of 210 
Millipore water (0.1% Lf). 211 
2.5.2. Simulated intestinal digestion 212 
For in-vitro intestinal digestion, initial digestion of the encapsulated micro-gel particles (100 mg) in 213 
SGF (2 mL) was conducted according to Section 2.5.1. for 2 h at 37 ºC. Then, 2 mL of pre-warmed 214 
(37 ºC) SIF was added. The pH was adjusted to 7.5 with 1 M NaOH (~ 60 µL). The entire sample 215 
was incubated at 37 ºC under constant shaking (100 horizontal strokes/min) for a set interval of time 216 
(10, 20, 30 & 60 min). At the end of the set time interval, the digested sample was diluted with 46 217 
mL of Millipore water to achieve 0.1% Lf. This diluted sample was instantly used for SDS-PAGE 218 
gel electrophoresis. The samples from the SGF digestion (digested for 2 h) were used as controls in 219 
the SDS-PAGE gel electrophoresis.   220 
2.6. SDS-PAGE gel electrophoresis 221 
The amount of Lf remaining undigested in the SGF and SIF after the set length of time was 222 
determined by gel electrophoresis (SDS-PAGE) using 4 – 20% precast polyacrylamide gels under 223 
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reducing conditions. 100 µL of each sample (0.1% Lf) described in Sections 2.4.or 2.5. was added 224 
to 200 µL of SDS-loading buffer (70 mM Tris-Cl, pH 6.8; 26%  glycerol; 2.11% SDS and 0.01% 225 
bromophenol blue dye). Finally, 5 µL of β-mercaptoethanol was added to each sample. 226 
Subsequently it was heated at 95 ºC for 5 minutes. The dilution of Lf samples (0.1% Lf), mixing 227 
with loading buffer (1:2) and heating (95 ºC) were carried out continuously with very short time 228 
lapse in-between to minimize further digestion by the enzymes pepsin and pancreatin. These 229 
samples were kept frozen until loading onto the SDS-PAGE gels. 230 
The frozen samples were thawed, vortexed and 5 µL was loaded into the wells of a SDS-PAGE gel. 231 
Electrophoresis was conducted at 200 V for 47 minutes in a Mini-PROTEAN tetra cell system. 232 
Following this, the SDS-PAGE gel was dipped in a fixative solution (20% acetic acid in 40% 233 
methanol) for 5 minutes, drained and stained overnight under constant shaking (160 rpm) (IKA® 234 
KS 130B, GmbH& Co. KG, Germany) at room temperature (22 ± 2 ºC) with Coomossie brilliant 235 
blue R-250 solution containing 34% methanol. The SDS-PAGE gel was de-stained in de-staining 236 
solution (1% acetic acid) for 24 hours with 2 changes. Scanning of SDS-PAGE gel was done with 237 
Gel Densitiometer (GS-800 Calibrated Densitiometer, UMAX Technologies, Model UTA−2100XL, 238 
Taiwan). The amount of intact Lf was normalized based on the relative quantity of control Lf 239 
sample in lane T0 using Quantity One® software.  240 
2.7. Stability of micro-gel particles 241 
Micro-gel particle stability and integrity during in-vitro digestion was observed by recording 242 
microscope images using an optical microscope (Prism Optical PRO 2300T, Scientific instrument, 243 
Brisbane, Australia). Images were recorded using the software TSView7 under an eye piece Plan 244 
achromat 10/0.25 at different time intervals during in-vitro gastric and intestinal digestion. The 245 
particle size distribution of the micro-gel particles during in-vitro digestion was also analyzed using 246 
Mastersizer 2000 as described above.  247 
2.8. Statistical analysis 248 
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Results are presented as mean ± SD of triplicate experiments where applicable. For other 249 
experiments, the number is indicated by n. The significance of differences between the values 250 
(where applicable) were analyzed by MiniTab 16 software using Analysis of Variance (ANOVA) 251 
with Tukey’s HSD post hoc test at family error rate 5 at 95% confidence level.  252 
3. Results and discussion 253 
3.1. Encapsulation of Lf in alginate micro-gel particles 254 
The encapsulation of Lf in alginate micro-gel particles using the Progel microencapsulating device 255 
gave the highest product recovery for the combination of a 2% Lf-alginate mixture (1:1) with 0.1 M 256 
CaCl2 as the cross-linking solution for native-Lf (86 ± 8%). The actual product recovery of the 257 
micro-gel particles containing apo-Lf and holo-Lf are not included here. During the atomization of 258 
the Lf-alginate solution with apo- and holo-Lf, it was observed that the micro-gel particle production 259 
was non-homogenous leading to a wide distribution of the particle size. In addition, in some 260 
instances aggregation of particles were observed. The difference in behavior of the different forms of 261 
Lf might be due to the differences in the viscosity of the mixtures. The viscosities of Lf-alginate 262 
mixtures with apo- (721 ± 38 mPa s) and holo-Lf (514 ± 14 mPa s) were significantly lower than 263 
that with native-Lf (1297 ± 36 mPa s) (Bokkhim et al., 2015). In order to be able to compare the 264 
micro-gel particles with different forms of Lf, the same composition has to be used for all Lf-265 
alginate mixtures. Thus we limited the encapsulation study to the mixing ratio of 1:1 and total solids 266 
content of 2%. In addition, from our previous study (Bokkhim et al., 2015), within the 2% total 267 
solids content of Lf-alginate mixture, changing the mixing ratio alone was not able to increase the 268 
viscosity of the mixtures with apo- and holo-Lf to the required level for improved encapsulation. 269 
Increasing the concentration of calcium in the cross-linking solution to 0.2 M improved the micro-270 
gel particle formation process for Lf-alginate mixtures containing apo- and holo-Lf however, the Lf 271 
entrapment efficiency was affected concomitantly as discussed below. The colors of the gel particles 272 
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were imparted by the colors of Lf used, and the difference in color of gel particles was very distinct 273 
in their freeze-dried powdered form (Fig. 2).  274 
The colors of the freeze-dried powders of the micro-gel particles made using 0.2 M CaCl2 solution 275 
appeared lighter than the freeze-dried powders of the micro-gel particles made from 0.1 M CaCl2 276 
solution in agreement with the observed lower encapsulation efficiency. The loss of Lf in the filtrate 277 
solution which showed very light pinkish taint was also observed. Kim (1990) has shown that the 278 
use of higher calcium ion concentration during cross-linking of alginate causes a rapid shrinking of 279 
the alginate gel leading to formation of water cavities within the gelled layer of the particles due to 280 
rapid release of bound water from the alginate network. In agreement with this, studies have shown 281 
that the formation of a compact gel results when using high calcium ion concentrations and this is 282 
associated with possible collapse of some junction zones leading to increased pore sizes (Donati, & 283 
Paoletti, 2009) and formation of inhomogeneous gel structure which can affect the permeability 284 
(Skjåk-Bræk, Grasdalen, & SmidsrØd, 1989; Bellich, Borgogna, Cok, & Cesàro, 2011). This 285 
ultimately will cause greater diffusion of Lf during micro-gel particle formation. In order to fully 286 
elucidate the effect of the physico-chemical properties of Lf on the gelation process using the Progel 287 
micro-encapsulating device, further investigations would be required, especially with regards to 288 
calcium ion concentration and to optimize the encapsulation process for apo- and holo-Lf.   289 
Figure 2.  290 
3.2. Characterization of Lf-alginate micro-gel particles 291 
3.2.1. Calcium and protein content  292 
The calcium and protein content of the Lf-alginate micro-gel particles are presented in Table 1. 293 
Apart from the micro-gel particles having apo-Lf (0.1 M CaCl2), the calcium content of all other gel 294 
particles were not significantly different.  Increasing the calcium concentration (0.2 M) in the cross-295 
linking solution did not affect the calcium uptake by the micro-gel particles. The reason for higher 296 
calcium uptake by the micro-gel particles having apo-Lf (0.1 M CaCl2) is not very clearly 297 
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understood. The control alginate micro-gel particles (2%) showed no significant difference in 298 
calcium content of Lf-alginate micro-gel particles produced using solution of CaCl2 at 0.1 M (81 ± 7 299 
mg Ca2+/g alginate) and 0.2 M (85 ± 9 mg Ca2+/g alginate). This indicates that the calcium content of 300 
the washed micro-gel particles fabricated by the impinging aerosol technique using a cross-linking 301 
time of 30 minutes is not affected by the calcium concentration of the cross-linking solution. This 302 
might be related to the size of the gel particles, since it will take a short time for calcium to diffuse 303 
into these micron-sized particles. 304 
The protein content of the micro-gel particles was significantly higher when lower calcium 305 
concentration (0.1 M) was used in the cross-linking solution. This illustrates the importance of 306 
gelation rate to retain the core material. When using a high calcium concentration (0.2 M) in the 307 
cross-linking mist, very rapid formation of densely cross-linked (Jao, Ho, & Chen, 2010) gel 308 
particles could lead to excessive leaching of the Lf. 309 
Table 1 310 
3.2.2. Particle size measurement 311 
The particle size of the micro-gel particles encapsulating native-Lf was measured using a 312 
Mastersizer 2000. The particle size expressed as volume weighted mean D (4,3), of fresh micro-gel 313 
particles prior to washing were significantly smaller (40 ± 1 µm) (P < 0.05) than the micro-gel 314 
particles after washing (70 ± 8 µm). This could be due to osmotic swelling during washing with 315 
Millipore water in the absence of calcium. The particle sizes of rehydrated freeze-dried micro-gel 316 
particles in Millipore water (at 22 ± 2 ºC) were not significantly different (66 ± 3 µm) from that of 317 
freshly washed micro-gel particles. Thus, the shape and size of the micro-gel particles were not 318 
affected by freeze-drying which is based on the rapid sublimation of frozen water from the frozen 319 
alginate gel particles. Microscopic pictures of unwashed, washed and rehydrated freeze-dried micro-320 
gel particles are presented in Figure 3 (A, B & C). Freeze-drying helped to create a porous gel 321 
structure without significant collapse of primary micro-gel particles which recovered the original 322 
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shape and size when rehydrated. A similar result has been reported by Smrdel, Bogataj and Mrhar 323 
(2008) for freeze-dried alginate particles. Furthermore, it has been reported that freeze drying of a 324 
hydrocolloid gel produces stable solid cellular structures. The porous nature of such cellular 325 
structures has enabled its use as carrier materials for drugs and other bioactive compounds enabling 326 
their controlled release (Nussinovitch, A., 2005). 327 
Figure 3 (A, B & C). 328 
3.3. In-vitro digestion of encapsulated Lf 329 
3.3.1. Simulated gastric digestion 330 
The SDS-PAGE gel of apo-, native- and holo-Lf after 2 h in-vitro digestion in SGF (180 U 331 
pepsin/mg Lf) is presented in Figure 4 (A) and that of Lf encapsulated in alginate micro-gel 332 
particles in Figure 4 (B). In both SDS-PAGE gel (4 A & B), the major band in each lane 333 
corresponding    to 75 kDa is the Lf. The lanes T0 represent the control samples, pure Lf at time 0 in 334 
the SDS-PAGE gel (4 A) and encapsulated Lf at time 0 in SDS-PAGE gel (4 B). Their 335 
corresponding amounts based on densitiometric analysis of the 75 kDa bands are taken as 100% to 336 
normalize the relative amount of Lf in other lanes. These lanes showing several minor bands at 337 
lower molecular mass could be due to the breakdown of Lf in the reducing conditions during 338 
sample preparation for SDS-PAGE gel electrophoresis. In-vitro digestion of apo- and native-Lf 339 
produced major bands at the vicinity of 50 kDa and 15 kDa whereas holo-Lf produced major bands 340 
at 37 kDa but only minor bands at 50 kDa (Figure 4 A). Similar bands were seen but at lower 341 
intensity for encapsulated Lf (Figure 4 B). This showed that the action of pepsin on Lf does not 342 
always produce fragments of similar molecular mass with different forms of Lf. SDS-PAGE was 343 
not able to detect pepsin at the level of concentration used in the experiment. 344 
Comparative densitiometric analysis of the Lf and encapsulated Lf are presented in Figure 5. 345 
Among the samples of pure Lf, holo-Lf was more resistant towards pepsin digestion as compared to 346 
apo- and native-Lf. No significant difference between the values of undigested holo-Lf was noted 347 
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for different time intervals, even after 2 h in SGF where 96 ± 0.2% holo-Lf remained intact. Apo- 348 
and native-Lf were more prone to pepsin digestion in the initial 30 min, but their concentrations 349 
remained the same thereafter in the SGF. The result showed that only 54 ± 6% of apo- and 57 ± 6% 350 
of native-Lf remained after 30 min in the SGF. Almaas, Holm, Langsrud, Flengsrud and Vegarud 351 
(2006) also reported similar trend where digestion of Lf from caprine whey by human gastric juice 352 
occurred within the initial 22 − 30 min and with no observable reaction thereafter. These values are 353 
in agreement with an in-vivo digestion study of bovine Lf by Steijns, Brummer, Troost and Saris 354 
(2001), where 62% of apo-Lf and 79% of holo-Lf remained after 30 min. Iron saturated Lf has been 355 
reported to be more resistant to proteolysis than the corresponding apo-Lf (Brock et al., 1976; 356 
Brines, & Brock, 1983). It has been reported that the compact molecular conformation due to the 357 
binding of iron to the Lf, reduces its sensitivity to proteolysis (Sánchez et al., 1992).  358 
Among the samples of encapsulated Lf, the digestion profile was not significantly different for the 359 
different forms of Lf nor for different time intervals in the SGF. The micro-gel particles remained 360 
intact throughout the in-vitro digestion in SGF for 2 h (Fig. 6 B) and a minimum of 76 ± 9% of the 361 
encapsulated Lf remained undigested. This showed that encapsulating Lf, especially apo- and 362 
native-Lf, in alginate micro-gel particles delays the action of pepsin by limiting its access to Lf 363 
thereby leading to lower Lf degradation. The intermolecular interactions which occur between Lf 364 
and alginate (Peinado, et al., 2010; Bokkhim et al., 2015; David-Birman, Mackie, & Lesmes, 2013) 365 
could have played a role in making Lf less available for pepsin degradation. It should be noted that 366 
during the gastric digestion, an increase in pH from 2.0 to 3.5 was observed for all types of micro-367 
gel particles. This increase in the pH will cause a lower activity of pepsin. Pepsin activity is 368 
maximum at pH 1.5 – 2.5 (Piper, & Fenton, 1965) and decreases by nearly 40% at pH 3.5 369 
(Johnston, Dettmar, Bishwokarma, Lively, & Koufman, 2007). However, even at this reduced 370 
activity, there is still a large excess of pepsin present (equivalent to 108 U/mg Lf). Some 371 
encapsulated Lf is being digested by pepsin, which is possible as either the peripheral Lf diffuses 372 
out of the particles (<0.1% in pH (2.0) adjusted Millipore water in 2 h) and become available to 373 
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and act on the Lf, though at a slower rate. 375 
Figure 4 (A & B).  376 
Figure 5.   377 
3.3.2. Simulated intestinal digestion 378 
The in-vitro stability profile of the micro-gel particles through microscopic images is shown in 379 
Figure 6 (A, B & C). From these images, it can be seen that the micro-gel particles remained intact 380 
throughout the in-vitro digestion in the SGF for 2 h (Fig. 6 B) whereas the particles disintegrated in 381 
the SIF (Fig. 6 C). The presence of phosphate salts and a higher pH (7.5) in the SIF could have led 382 
to the dissolution of the micro-gel particles. High pH and the presence of salts (phosphates, sodium 383 
etc.) have been attributed to the disintegration of alginate particles leading to burst release of 384 
encapsulated proteins, thus exposing it to the proteolytic enzymes (George, & Abraham, 2006; Shi 385 
et al., 2005). 386 
Figure 6 (A, B & C).  387 
Figure 7 (A) and 7 (B) show the SDS-PAGE gel of the different forms of Lf after 1 h in-vitro 388 
digestion in SIF and of encapsulated Lf during successive in-vitro digestion in the SGF for 2 h 389 
followed by 1 h in SIF, respectively. In both SDS-PAGE gels (7 A & B), Lf appeared as the major 390 
bands in each lane corresponding to 75 kDa. The lanes T0 represent the control Lf samples without 391 
any digestion for SDS-PAGE gel (7 A) and encapsulated Lf after 2 h in-vitro digestion in SGF for 392 
SDS-PAGE gel (7 B). With pure Lf, in-vitro digestion of all Lf samples produced major bands at 393 
the vicinity of 50 kDa and 37kDa with minor bands spread in-between 20 and 30 kDa. Some intact 394 
holo-Lf was still detected after digestion in SIF for 1 h but the amount decreased with time. 395 
Furthermore, with holo-Lf, the minor bands within the 20 – 30 kDa region were of higher intensity 396 
compared to apo- and native-Lf. Encapsulated Lf also produced similar bands to pure Lf but with 397 
additional minor bands below 20 kDa (Figure 7 B). Loading of the pancreatin in the SDS-PAGE 398 
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mostly present around 25 kDa (trypsin, ribonuclease & protease) and two very faint bands in-400 
between the 10 – 15 kDa range (SDS-PAGE gel profile image not shown). 401 
Comparative digestion profiles of pure Lf and encapsulated Lf by densitiometry is given in Figure 402 
8. The digestion of all forms of Lf by pancreatin was very rapid and after 10 mins both apo- and 403 
native-Lf were completely digested. Holo-Lf was showed some resistance to pancreatin digestion 404 
but the amount of holo-Lf remaining after 10 min was very low (< 5%).  It has been reported that 405 
bile salts aid in the hydrolysis of intact proteins during in-vitro duodenal digestion (Martos, 406 
Contreras, Molina, & López-Fandiño, 2010). Brock, Arzabe, Lampreave and Piñeiro (1976) have 407 
reported that holo-Lf is sensitive to trypsin digestion and that only 6% Lf remained intact after 3 h 408 
digestion. The difference in survival time in our study can be attributed to the use of different 409 
enzyme combination and protein to enzyme ratio. 410 
The digestion pattern for encapsulated Lf in the micro-gel particles was not significantly different 411 
from that of the corresponding Lf. This can be attributed to the low stability of the micro-gel 412 
particles in SIF where rapid disintegration was observed. This would have caused the Lf to be 413 
released into the digest making it prone to the action of pancreatin. Research has shown that intact 414 
Lf from Lf-alginate nano-particles, which survived the gastric digestion beyond 40 min, was 415 
subsequently digested in the duodenum.  416 
Figure 7 (A & B).  417 
Figure 8.  418 
It has been shown that different concentrations of calcium in the cross-linking solution can give rise 419 
to differences in the calcium gradient which is produced during the formation of gel particles. Such 420 
different gelling zones affect the homogeneity of the particles (Donati & Paoletti, 2009). To 421 
understand the effect of the calcium gradient of the alginate micro-gel particles on the digestibility 422 
of encapsulated Lf, in-vitro gastric and intestinal digestion was conducted following the same 423 
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digested by the pepsin during in-vitro digestion in the SGF as compared to gel particles produced 425 
using 0.1 M CaCl2 (data not shown). The change in porosity of the micro-gel particles could be a 426 
contributing factor to this observation as it increases the accessibility of Lf to the action of pepsin 427 
along with possibility of higher Lf leaching. The in-vitro simulated intestinal digestion profile was 428 
similar to that observed for the 0.1 M CaCl2 cross-linked micro-gel particles. The only difference in 429 
the behavior of the 0.2 M CaCl2 cross-linked micro-gel particles was an increased time for 430 
disintegration in the SIF. Thus, longer time for disintegration of the micro-gel particles did not lead 431 
to greater resistance to proteolytic enzymes during in-vitro digestion. 432 
It was observed that the Lf and encapsulated Lf to some extent was digested in the SGF by pepsin 433 
into smaller peptide fragments (seen in the SDS-PAGE gels at the 2 h time-point, Fig. 4 A & B). 434 
Furthermore, peptide fragments were formed by pancreatin and were still present after 1 h of SIF 435 
treatment (Fig. 7 B). Research has shown that the pepsin hydrolysates, especially lactoferricin and 436 
lactoferrampin from Lf possess strong antimicrobial activity (Tomita et al., 2009; van der Kraan et 437 
al., 2004). Almaas et al. (2006) reported that the digestion products of pepsin and trypsin of porcine 438 
origin still conserve their antibacterial properties, though further degradation could lead to total loss 439 
of activity. In addition, research has shown that the iron binding capacity of holo-Lf is unaffected 440 
by proteolysis (Sánchez, Calvo, & Brock, 1992) by trypsin and chymotrypsin (Brines & Brock, 441 
1983). Wakabayashi, Yamauchi and Takase (2006) has claimed that partially digested bovine Lf 442 
peptides retain their biological activities and can exert various physiological effects similar to that 443 
of intact Lf. The current study has demonstrated that the encapsulation of Lf in micro-gel particles 444 
can delay its hydrolysis by pepsin in SGF, such that it enters the SIF where it encounter further 445 
digestion by pancreatin releasing the peptides later in the digestion process as compared to un-446 
encapsulated Lf. The peptides originating from native- and holo-Lf remain in the SIF in 447 
considerable amounts for more than 30 min. Further work will be required to confirm that the 448 
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as predicted based on the previous work described.  450 
4. Conclusion 451 
The novel impinging aerosol technique (Progel) was successful at producing Lf-alginate micro-gel 452 
particles with an encapsulation efficiency of higher than 68%. Calcium concentration of 0.1 M in 453 
the cross-linking solution was found to be optimum to encapsulate a 2% mixture of Lf-alginate 454 
(1:1) and increasing the calcium ion concentration to 0.2 M led to lower entrapment efficiency of Lf 455 
by the micro-gel particles. The micro-gel particles had similar calcium content (except for apo-Lf) 456 
regardless of the concentration of calcium in the cross-linking solution. The particle size of the Lf-457 
alginate micro-gel particles were not affected by freeze drying and rehydration. In-vitro studies 458 
showed that encapsulated Lf (apo- and native-) were more resistant towards the action of pepsin in 459 
the SGF as compared to their corresponding pure Lf, but the effect of encapsulation was not 460 
significant for holo-Lf. The action of pepsin in SGF on Lf was more pronounced in the initial 30 461 
minutes and the Lf concentration remained constant thereafter. The encapsulation of Lf did not 462 
provide any significant delay in the digestion of Lf in the SIF. Holo-Lf was more resistant towards 463 
the action of pancreatin in SIF, and the amount of intact holo-Lf remaining after the initial 10 min 464 
was less than 5%. The findings of this research clearly demonstrate that encapsulation of Lf in 465 
alginate micro-gel particles offers protection of apo- and native-Lf from pepsin, the enzyme of the 466 
gastric juice. In the presence of salts and high pH, the alginate micro-gel particles dissolve to 467 
release the Lf in SIF. Pancreatin partly digested the released Lf in SIF and the peptide fragments 468 
produced survived the simulated intestinal condition for more than 30 min. 469 
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Caption for table supplied: 
Table 1 
Calcium and protein content of freeze-dried micro-gel particlesprepared from 2% Lf-alginate 
mixture (1:1) using three forms of Lf and two concentrations of CaCl2 solutions. 
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Table: 
Table 1 
Sample name Protein form [Ca2+] (M) Calcium content 
(mg/g alginate) 
Protein content 
(%) 
Alg 1 None 0.1 81 ± 7B - 
Alg 2 None 0.2 85 ± 9B - 
MA 1 Apo-Lf 0.1 104 ± 2A 39.4 ± 0.5A 
MA 2 Apo-Lf 0.2 85 ± 2B 20 ± 7B 
MN 1 Native-Lf 0.1 92 ± 2AB 48 ± 2A 
MN 2 Native-Lf 0.2  87 ± 1B 20 ± 1B 
MH 1 Holo-Lf 0.1  82 ± 2B 48 ± 2A 
MH 2 Holo-Lf 0.2  82 ± 3B 12.9 ± 0.3B 
Mean values of calcium content and protein content (vertical columns) that do not share a letter 
are significantly different at P < 0.05. 
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Captions for Figures supplied: 
Figure Caption Remarks/Format 
Fig. 1 Schematic diagram showing the novel Impinging aerosol 
apparatus (Adapted from Ching et al., 2015). 
TIFF 
Fig. 2 Pictures of freeze-dried Lf and Lf-alginate micro-gel particles 
(Top row: Three forms of Lf; middle row: 2% Lf-alginate 
micro-gel particles formed using 0.1 M CaCl2; bottom row: 
2% Lf-alginate micro-gel particles formed using 0.2 M 
CaCl2). M denotes the Lf-alginate mixture and A, N & H 
represent apo-, native- &holo-Lf, respectively. 1 & 2 indicate 
the calcium chloride concentration used in the cross-linking 
solution, 0.1M and 0.2M, respectively). 
JPEG 
Fig. 3 Microscopic pictures of MN 1 gel particles A) As prepared,   
B) Washed & C) Freeze-dried & rehydrated in Millipore 
water. 
JPEG 
Fig. 4 SDS-PAGE profile of Lf after 2 h in-vitro digestion in SGF 
of (A) apo-, native- and holo-Lf and (B) Lf from micro-gel 
particles MA 1, MN 1 & MH 1 at different time intervals (T 
in min). T0 represents the control sample in each group. The 
last lane is in each gel is the molecular marker (kDa). 
JPEG 
Fig. 5 Digestion profile of Lf (band at 75 kDa) based on 
densitiometric values after in-vitro digestion in SGF for 2 h. 
The bars across groups that do not share a letter is 
significantly different at P < 0.05 (n = 2). 
TIFF 
Fig. 6 Microscopic pictures of freeze-dried micro-gel particles (MN 
1) during in-vitro digestion at (A) Time 0 (SGF),          (B) 
Time 2 h (SGF) & (C) Time 4 h (2 h in SGF + 2 h in SIF). 
JPEG 
Fig. 7 SDS-PAGE profile of Lf after in-vitro digestion of (A) apo-, 
native- and holo-Lf in SIF for 1 h and (B) Lf from micro-gel 
particles MA 1, MN 1 & MH 1 in SGF for 2 h and 
subsequent digestion in SIF for 1 h at different time intervals 
(T in min). T0 represents the control sample in each group. 
The last lane in each gel is the molecular marker (kDa). 
JPEG 
Fig. 8 Digestion profile of Lf based on densitiometric values after 
in-vitro digestion in SIF. For pure Lf, digestion was done in 
SIF for 1 hr and for the micro-gel particles MA 1, MN 1 & 
MH 1, digestion was done in SGF for 2 h with subsequent 
digestion in SIF for 1 h. The bars across groups that do not 
share a letter is significantly different at P < 0.05 (n = 2). 
TIFF 
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Highlights: 
1. Resistance to enzymes and acid in the environment is affected by the forms of 
Lactoferrin (Lf). 
2. Encapsulating Lf in alginate micro-gel particles can provide protection from 
enzymatic and acidic action. 
3. Encapsulated Lf is released in the simulated intestinal fluid by dissolution of 
the micro-gel particles. 
4. Holo-Lf is resistant to the action of enzyme and acid without encapsulation. 
 
 
